Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer

Nina R. Shah(Moores Cancer Center), David D. Schlaepfer(UC San Diego Health System), Denise C. Connolly(Fox Chase Cancer Center), Christine Jean(Centre National de la Recherche Scientifique), Kristy Ward(University of California San Diego), Nichol Miller(Pfizer (United States)), Sean Uryu(Pfizer (United States)), Florian J. Sulzmaier(National Foundation for Cancer Research), Isabelle Tancioni(University of California San Diego), Christine Lawson(University of California San Diego), Xiao Lei Chen(Xiamen University)
Gynecologic Oncology
April 27, 2014
Cited by 54


Related Papers